关注
Robert Mcgeachan
Robert Mcgeachan
在 ed.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Synaptic degeneration in Alzheimer disease
M Tzioras, RI McGeachan, CS Durrant, TL Spires-Jones
Nature Reviews Neurology 19 (1), 19-38, 2023
1352023
Synaptic oligomeric tau in Alzheimer’s disease—a potential culprit in the spread of tau pathology through the brain
M Colom-Cadena, C Davies, S Sirisi, JE Lee, EM Simzer, M Tzioras, ...
Neuron 111 (14), 2170-2183. e6, 2023
472023
Characterizing the molecular and immune landscape of canine bladder cancer
KE Cronise, S Das, BG Hernandez, DP Regan, DD Dailey, RI McGeachan, ...
Veterinary and comparative oncology 20 (1), 69-81, 2022
162022
Integrated methylome and phenome study of the circulating proteome reveals markers pertinent to brain health
DA Gadd, RF Hillary, DL McCartney, L Shi, A Stolicyn, NA Robertson, ...
Nature Communications 13 (1), 4670, 2022
142022
Predictive blood biomarkers and brain changes associated with age-related cognitive decline
TS Saunders, FE Pozzolo, A Heslegrave, D King, RI McGeachan, ...
Brain Communications 5 (3), fcad113, 2023
82023
TL Spires-Jones Synaptic degeneration in Alzheimer disease., 2023, 19
M Tzioras, RI McGeachan, CS Durrant
DOI: https://doi. org/10.1038/s41582-022-00749-z. PMID: https://www. ncbi …, 0
5
Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat
RI McGeachan, T Schwarz, DA Gunn-Moore, K Marioni-Henry
Journal of Feline Medicine and Surgery Open Reports 6 (1), 2055116920922648, 2020
42020
p-tau Ser356 is associated with Alzheimer’s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003
LW Taylor, EM Simzer, C Pimblett, OTT Lacey-Solymar, RI McGeachan, ...
Acta Neuropathologica 147 (1), 7, 2024
32024
The genetic and epigenetic profile of serum S100β in the Lothian Birth Cohort 1936 and its relationship to Alzheimer’s disease
DA Gadd, RI McGeachan, RF Hillary, DL McCartney, SE Harris, ...
Wellcome Open Research 6, 2021
22021
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer’s disease
M Colom-Cadena, J Toombs, E Simzer, K Holt, R McGeachan, J Tulloch, ...
Acta Neuropathologica 147 (1), 1-22, 2024
12024
Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003
LW Taylor, EM Simzer, C Pimblett, O Lacey-Solymar, RI McGeachan, ...
bioRxiv, 2023.08. 28.553851, 2023
12023
Evidence for trans-synaptic propagation of oligomeric tau in Progressive Supranuclear Palsy
RI McGeachan, L Keavey, JL Rose, EM Simzer, YY Chang, ...
medRxiv, 2022.09. 20.22280086, 2022
12022
The genetic and epigenetic profile of serum S100β in the Lothian Birth Cohort 1936 and its relationship to Alzheimer’s disease
D A Gadd, R I McGeachan, R F Hillary, D L McCartney, S E Harris, ...
Wellcome Open Research 6, 306, 2022
12022
Synaptic gene expression changes in frontotemporal dementia due to the MAPT 10+ 16 mutation
O Dando, R McGeachan, J McQueen, P Baxter, N Rockley, H McAlister, ...
medRxiv, 2024
2024
Phylogenetic divergence of GABAB receptor signalling in neocortical networks over adult life.
MA Wilson, LW Taylor, S Meftah, RI Mcgeachan, T Modebadze, ...
bioRxiv, 2024.06. 04.597285, 2024
2024
Opposing roles of physiological and pathological amyloid-β on synapses in live human brain slice cultures
RI McGeachan, S Meftah, LW Taylor, JH Catterson, D Negro, J Tulloch, ...
bioRxiv, 2024.02. 16.580676, 2024
2024
Clinical course in corticobasal syndrome and corticobasal degeneration: implications for diagnosis and management
RI McGeachan, D King
Brain Communications 5 (6), fcad321, 2023
2023
Tau accumulates in synaptogyrin-3 positive synapses in Progressive Supranuclear Palsy
R McGeachan, MP Spires-Jones, M Gilmore, J Rose, TL Spires-Jones
2022
the Lothian Birth Cohort 1936 and its relationship t o Alzheimer’s disease [version 2; peer review: 2 approved]
DA Gadd, RI McGeachan, RF Hillary, DL McCartney, SE Harris, ...
2022
系统目前无法执行此操作,请稍后再试。
文章 1–19